Herby the annual output of Iran J Public Health, for the year 2024 is presented. Simultaneously the output of the years 2021–2023 are presented comparatively as well.
The total number of manuscripts received during 2024 was 2048 cases from 56 countries. Of course, only the country of the corresponding author(s) was considered, so altogether much more countries we had in our package. It is worth mentioning that in some cases there were two corresponding authors in share. This year, Iran had the highest rate of submission (691), followed by China (525) and Turkey (291) (Table 1). Fig. 1 presents the total number of articles published during 2021–24 in terms of the frequency of submission, rejection and acceptance rate.
Table 1:
The frequency of manuscripts received by Iran J Public Health during 2024 in terms of the frequency of submission, rejection and acceptance rate*
| No. | Country | Submission | Reject | Accepted |
|---|---|---|---|---|
| 1 | Algeria | 3 | 3 | 0 |
| 2 | Armenia | 1 | 1 | 0 |
| 3 | Australia-USA- | 1 | 0 | 1 |
| Emirates | ||||
| 4 | Azerbaijan | 3 | 3 | 0 |
| 5 | Bangladesh | 1 | 1 | 0 |
| 6 | Bosnia | 3 | 1 | 1 |
| 7 | Brazil | 1 | 1 | 0 |
| 8 | Bulgaria | 3 | 2 | 1 |
| 9 | Canada | 2 | 2 | 0 |
| 10 | China | 525 | 388 | 61 |
| 11 | Cyprus | 4 | 3 | 0 |
| 12 | Denmark | 1 | 0 | 1 |
| 13 | Egypt | 5 | 5 | 0 |
| 14 | Ethiopia | 1 | 1 | 0 |
| 15 | France | 1 | 0 | 0 |
| 16 | Greece | 1 | 1 | 0 |
| 17 | India | 45 | 41 | 3 |
| 18 | Indonesia | 154 | 142 | 9 |
| 19 | Iran | 691 | 589 | 58 |
| 20 | Iran-Iraq | 1 | 0 | 1 |
| 21 | Iraq | 33 | 33 | 0 |
| 22 | Japan | 4 | 1 | 3 |
| 23 | Jordan | 8 | 8 | 0 |
| 24 | Kazakhstan | 8 | 7 | 1 |
| 25 | Korea | 47 | 23 | 20 |
| 26 | Kyrgyzstan | 1 | 0 | 1 |
| 27 | Malaysia | 29 | 22 | 5 |
| 28 | Malaysia-Oman | 1 | 0 | 1 |
| 29 | Mexico | 2 | 2 | 0 |
| 30 | Montenegro | 9 | 5 | 3 |
| 31 | Morocco | 18 | 17 | 1 |
| 32 | Nepal | 1 | 0 | 0 |
| 33 | Nigeria | 5 | 4 | 0 |
| 34 | Oman | 3 | 2 | 1 |
| 35 | Pakistan | 41 | 40 | 1 |
| 36 | Pakistan- USA | 1 | 0 | 1 |
| 37 | Palestine | 11 | 10 | 1 |
| 38 | Peru | 2 | 2 | 0 |
| 39 | Philippines | 1 | 1 | 0 |
| 40 | Poland | 3 | 3 | 0 |
| 41 | Russia | 3 | 3 | 0 |
| 42 | Rwanda | 1 | 1 | 0 |
| 43 | Saudi Arabia | 22 | 22 | 0 |
| 44 | Serbia | 18 | 9 | 9 |
| 45 | Singapore | 1 | 0 | 1 |
| 46 | Somalia | 1 | 0 | 0 |
| 47 | South Africa | 5 | 5 | 0 |
| 48 | Spain | 1 | 1 | 0 |
| 49 | Taiwan | 1 | 0 | 0 |
| 50 | Thailand | 18 | 17 | 0 |
| 51 | Tunisia | 1 | 1 | 0 |
| 52 | Turkey | 291 | 266 | 10 |
| 53 | UK | 1 | 1 | 0 |
| 54 | USA | 2 | 2 | 0 |
| 55 | Vietnam | 5 | 4 | 0 |
| 56 | Yemen | 2 | 2 | 0 |
| Total | 2048 | 1698 | 195 |
Note: Some manuscripts submitted during 2024, are still in the process of peer review so we have no idea of their destination. This is the reason of discrepancies in some rows.
The countries are mentioned based on the corresponding authors’ countries, so there are some mixed countries in the table.
Fig. 1:
Total number of articles submitted during 2021–24 in the context of the frequency of submission, rejection and acceptance rate.
Out of total submission of 2048 articles during 2024, 1698 articles were rejected after initial in-house evaluation in addition to subsequent peer review. Therefore, the acceptance rate for this year was 9.5%.
AS usual, during the last year, we screened all submitted papers using iThenticate plagiarism checker software to check the probable plagiarism. We tried mostly to ask the authors to correct their articles for minor plagiarism. Overall, we are bound to Committee of Publication Ethics (COPE), so we observe its rules on how to monitor the cases detected as plagiarism. Fortunately, only, 6 articles were rejected due to major plagiarism.
The Journal continued its policy as for exact peer review rules including in-house evaluation followed by double blind peer review system. Fig. 2, demonstrates the total number of articles published during 2021–24 in terms of the percentage of acceptance and rejection rate. Some manuscripts submitted during 2024, are still in the process of peer review so we have no idea of their destination. However, the rejection rate in 2024 was 83%.
Fig. 2:
The percentage of acceptance and rejection rate during 2021–24.
The types of articles published during 2021–24 are shown in Fig. 3. Accordingly, Original Articles had the highest rate of publication during the last four years. Our prefer policy is to publish authentic review articles as much a possible.
Fig. 3:
Total number of articles during 2021–24 based on the type of published papers.
Due to the high flow of submitted manuscripts, in some cases, the authors were asked to change the format of “Original Article” to “Letter to the Editor”.
The Impact Factor (IF) announced by Clarivate Analytics (Formerly ISI) for the year 2023 was 1.3, and 4007 citations, nearly similar to previous years. According to https://www.scimagojr.com/journalsearch.php the H index of the journal was 53 until 2023, moreover the rank of the journal was Q3 (Fig. 4). Besides, SCOPUS has reported SJR as 0.36 for the year 2023.
Fig. 4:
Key Indicators announced by Scimagojr.com for the year 2023.
